Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
140-82-9
17626-34-5
23978-09-8
31249-95-3
23978-55-4
70384-51-9
13395-35-2 | 5-[(3aS,4S,6aR)-2-imino-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid | AA007MKE | MFCD00066150
25953-19-9 | Cefazolin acid | AA007N2H | MFCD00243010
25346-09-2 | 1-Propanesulfinic acid,3-amino- | AA007NKX | MFCD19203767
22589-72-6 | Methyl 2-(1-(furan-2-yl)ethylidene)hydrazinecarboxylate | AA007O4R | MFCD00792953
2124-57-4 | Menaquinone-7 | AA007OKC | MFCD06200757
22232-71-9 | 5-(4-Chlorophenyl)-3,5-dihydro-2H-imidazo[2,1-a]isoindol-5-ol | AA007OZH | MFCD00864480
216667-08-2 | ASB-14 | AA007PE4 | MFCD03456122
1187385-85-8 | 4-Iodo-1-(pyridin-4-ylmethyl)pyrazole | AA007POI | MFCD12913970
220227-66-7 | 2-Fluoro-5-(trifluoromethyl)phenylacetic acid | AA007Q3R | MFCD00061187
21402-26-6 | 4-Bromo-3-chloroaniline | AA007QK2 | MFCD00041311